Assessing blinding in randomised controlled trials of acupuncture: Challenges and recommendations

Chinese Journal of Integrative Medicine

Volumn 17, Issue 3, 2011, Pages 173-176

  Hopton, Ann K ^a   MacPherson, Hugh ^a,b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Foundation for Research into Traditional Chinese Medicine   (United Kingdom)

Author keywords

Acupuncture; Blinding assesment; Methodology; Reporting

Indexed keywords

ACCURACY; ACUPUNCTURE; CHRONIC PAIN; CLINICAL PROTOCOL; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STUDY DESIGN; TREATMENT OUTCOME; VALIDATION PROCESS;

ACUPUNCTURE THERAPY; DOUBLE-BLIND METHOD; GUIDELINES AS TOPIC; HUMANS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 79952550150     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0663-9     Document Type: Review

References (26)

1. Moher D. Reports of randomized trials: ensure they are transparent, accurate, and complete. J Chin Integr Med (Chin) 2010;8:601-603.
2. Manheimer E, White A, Berman B, Forys K, Ernst E. Meta-analysis: acupuncture for low back pain. Ann Intern Med 2005;142:651-663. (Pubitemid 40529962)
3. Manheimer E, Linde K, Lao L, Bouter LM, Berman BM. Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med 2007;146:868-877. (Pubitemid 351650487)
4. White A, Foster NE, Cummings M, Barlas P. Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology (Oxford) 2007;46:384-390. (Pubitemid 46344646)
5. Fu LM, Li JT, Wu WS. Randomized controlled trials of acupuncture for neck pain: systematic review and meta-analysis. J Altern Complement Med 2009;15:133-145.
6. Tough EA, White AR, Cummings TM, Richards SH, Campbell JL. Acupuncture and dry needling in the management of myofascial trigger point pain: A systematic review and meta-analysis of randomised controlled trials. Eur J Pain 2009;13:3-10.
7. Altman DG, Schulz KF, Moher D. Turning a blind eye: testing the success of blinding and the CONSORT statement. BMJ 2004;328:1135.
8. Schulz KF ADMD, CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Chin Integr Med (Chin) 2010;8:604-612.
9. Kolahi J, Bang H, Park J, Desbiens N. CONSORT 2010 and controversies regarding assessment of blindness in RCTs. Dent Hypotheses. In press 2010.
10. Boutron I, Estellat C, Ravaud P. A review of blinding in randomized controlled trials found results inconsistent and questionable. J Clin Epidemiol 2005;58:1220-1226. (Pubitemid 41608537)
11. Bang H, Flaherty SP, Kolahi J, Park J. Blinding assessment in clinical trials: A review of statistical methods and a proposal of blinding assessment protocol. Clin Res Regul Affairs 2010;27:42-51.
12. Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials 2004;25:143-156. (Pubitemid 38328755)
13. James KE, Bloch DA, Lee KK, Kraemer HC, Fuller RK. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation -a VA cooperative study. Stat Med 1996;15:1421-1434. (Pubitemid 26242551)
14. Scharf H, Mansmann U, Streitberger K, Witte S, Krämer J, Maier C, et al. Acupuncture and Knee Osteoarthritis. Ann Intern Med 2006;145:12-20.
15. Enblom A, Hammar M, Steineck G, Börjeson S. Can individuals identify if needling was performed with an acupuncture needle or a non-penetrating sham needle? Complement Ther Med 2008;16:288-294.
16. Hrobjartsson A, Forfang E, Haahr MT, ls-Nielsen B, Brorson S. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Int J Epidemiol 2007;36:654-663. (Pubitemid 47244571)
17. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-639. (Pubitemid 26278070)
18. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-694. (Pubitemid 32322245)
19. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
20. Sackett DL. Turning a blind eye: why we don't test for blindness at the end of our trials. BMJ 2004;328:1136.
21. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002;359:696-700. (Pubitemid 34203775)
22. Fergusson D, Glass KC, Waring D, Shapiro S. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 2004;328:432.
23. You XM, Qin X, Dong ZY, Wang GL. Integrated traditional Chinese and Western medicine versus Western medicine in treatment of arteriosclerosis obliterans: a systematic review of randomized controlled trials. J Chin Integr Med (Chin) 2010;8:917-927.
24. MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med 2010;28:83-93.
25. MacPherson H. Towards better reporting of interventions in clinical trials of acupuncture. J Chin Integr Med (Chin) 2010;8:801-802.
26. Miller LE, Stewart ME. The blind leading the blind: Use and misuse of blinding in randomized controlled trials. Contemp Clin Trials. In Press, Corrected Proof.